Skip to main content
. 2020 Mar 31;12(4):839. doi: 10.3390/cancers12040839

Figure 2.

Figure 2

Comparison between Kaplan–Meier overall survival curves of metastatic colorectal cancer cohort members on first-line treatment with biologic-based (bevacizumab or cetuximab, Bio + CT) or standard chemotherapy (CT) alone. FABIO project, Italy, 2010–2016.